LABORATORY CORP OF AMERICA HOLDINGS Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LABORATORY CORP OF AMERICA HOLDINGS for March 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2016 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,237 | 0 | 11,348 | 10.1 K to 11.3 K (+12.23 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Buy | M | 0.00 | 1,237 | 0 | 4,908 | 3.7 K to 4.9 K (+33.70 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Buy | M | 0.00 | 1,237 | 0 | 3,364 | 2.1 K to 3.4 K (+58.16 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Buy | M | 0.00 | 1,237 | 0 | 4,474 | 3.2 K to 4.5 K (+38.21 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Buy | M | 0.00 | 1,237 | 0 | 2,912 | 1.7 K to 2.9 K (+73.85 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,237 | 0 | 5,413 | 4.2 K to 5.4 K (+29.62 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Payment of Exercise | F | 115.49 | 124 | 14,321 | 30,539 | 30.7 K to 30.5 K (-0.40 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 0.00 | 1,237 | 0 | 30,663 | 29.4 K to 30.7 K (+4.20 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 0.00 | 1,237 | 0 | 14,272 | 13 K to 14.3 K (+9.49 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 400 | 0 | 12,770 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 115.49 | 133 | 15,360 | 2,205 | 2.3 K to 2.2 K (-5.69 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 400 | 0 | 2,338 | 1.9 K to 2.3 K (+20.64 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 400 | 0 | 2,700 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 115.49 | 124 | 14,321 | 7,773 | 7.9 K to 7.8 K (-1.57 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 400 | 0 | 7,897 | 7.5 K to 7.9 K (+5.34 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,626 | 0 | 27,658 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 115.49 | 778 | 89,851 | 7,596 | 8.4 K to 7.6 K (-9.29 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,626 | 0 | 8,374 | 6.7 K to 8.4 K (+24.10 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 463 | 0 | 3,121 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Sell | S | 115.32 | 309 | 35,634 | 18,066 | 18.4 K to 18.1 K (-1.68 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 115.49 | 154 | 17,785 | 18,375 | 18.5 K to 18.4 K (-0.83 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 463 | 0 | 18,529 | 18.1 K to 18.5 K (+2.56 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Option Exercise | M | 0.00 | 2,956 | 0 | 11,631 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Sell | S | 115.32 | 1,543 | 177,939 | 23,454 | 25 K to 23.5 K (-6.17 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Payment of Exercise | F | 115.49 | 1,413 | 163,187 | 24,997 | 26.4 K to 25 K (-5.35 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Boyle James T. Jr. | EVP,CEO of LabCorp ... | Buy | M | 0.00 | 2,956 | 0 | 26,410 | 23.5 K to 26.4 K (+12.60 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 6,076 | 0 | 43,128 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 115.49 | 2,905 | 335,498 | 94,489 | 97.4 K to 94.5 K (-2.98 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 6,076 | 0 | 97,394 | 91.3 K to 97.4 K (+6.65 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Keller Deborah L | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 11,710 | 0 | 18,270 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Keller Deborah L | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 1,220 | 0 | 29,980 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Keller Deborah L | CEO, Covance Drug D ... | Payment of Exercise | F | 115.49 | 4,213 | 486,559 | 19,754 | 24 K to 19.8 K (-17.58 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Keller Deborah L | CEO, Covance Drug D ... | Buy | M | 0.00 | 11,710 | 0 | 23,967 | 12.3 K to 24 K (+95.54 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Keller Deborah L | CEO, Covance Drug D ... | Payment of Exercise | F | 115.49 | 374 | 43,193 | 12,257 | 12.6 K to 12.3 K (-2.96 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Keller Deborah L | CEO, Covance Drug D ... | Buy | M | 0.00 | 1,220 | 0 | 12,632 | 11.4 K to 12.6 K (+10.69 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 536 | 0 | 10,564 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 7,680 | 0 | 11,100 | |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 115.49 | 200 | 23,098 | 8,577 | 8.8 K to 8.6 K (-2.28 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 536 | 0 | 8,777 | 8.2 K to 8.8 K (+6.50 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 115.49 | 3,179 | 367,143 | 8,241 | 11.4 K to 8.2 K (-27.84 %) |
| Mar 15 2016 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 7,680 | 0 | 11,420 | 3.7 K to 11.4 K (+205.35 %) |